Form 4 for SOPH SOPHiA GENETICS SA
Accepted 2026-06-22 16:01:35 ET · period of report 2026-06-18 · accession 0001840706-26-000222 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-22 16:01 | 2026-06-18 | SOPH | Ossipow Vincent | Dir | A - Grant | $5.46 | +19.7K | 522.9K | +4% | +$107.7K |
| D | 2026-06-22 16:01 | 2026-06-18 | SOPH | Ossipow Vincent | Dir | A - Grant | $5.46 | +28.8K | 138.6K | +26% | +$157.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-06-18 | A | A | 19,724 | $5.46 | 522,860 | D | — | — | (F1) Represents a restricted stock unit ("RSU") grant. Each RSU represents a contingent right to receive one ordinary share of the Issuer, subject to Reporting Person's continued service with the Issuer. The RSUs were granted on June 18, 2026 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders. |
| 2 | Derivative | Share Option (Right to Buy) | 2026-06-18 | A | A | 28,818 | $5.46 | 138,569 | D | $5.46 · — to 2036-06-18 | 28,818 Ordinary Shares | (F2) The share options were granted on June 18, 2026 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders, subject to the Reporting Person's continued service to the Issuer through the relevant vesting date. |